Recombinant Interleukin− 2 2 Immunotherapy Ameliorates Inflammation and Promotes the Release of Monoamine Neurotransmitters in the Gut-Brain Axis of …
Abstract Recombinant interleukin-22 (rIL-22) has been reported as a protective agent in
murine models of diseases driven by epithelial injury. Parasites have a circadian rhythm and …
murine models of diseases driven by epithelial injury. Parasites have a circadian rhythm and …
Therapeutic efficacy of candidate antischistosomal drugs in a murine model of schistosomiasis mansoni
OS Mohammad, HM Hussein, SW Abdel-Sayed… - Parasitology …, 2024 - Springer
Schistosomiasis is a neglected tropical disease associated with considerable morbidity.
Praziquantel (PZQ) is effective against adult schistosomes, yet, it has little effect on juvenile …
Praziquantel (PZQ) is effective against adult schistosomes, yet, it has little effect on juvenile …
In vitro and in vivo impacts of nifedipine and diltiazem on praziquantel chemotherapy in murine Schistosoma mansoni
NA Madbouly, M Emam, M Ayman, M Ayman… - Experimental …, 2022 - Elsevier
Aim This study was planned to evaluate the in vitro and in vivo antischistosomal effects of
the widely used antihypertensive drugs, nifedipine (NIF) and diltiazem (DTZ), and their …
the widely used antihypertensive drugs, nifedipine (NIF) and diltiazem (DTZ), and their …
Modelling approaches to predict and evaluate schistosomiasis immunization utilizing SEA loaded on chitosan nanoparticles via liver tissue differentiation and …
S Etewa, AA Al-Hoot, H Sharaf… - Parasitologists …, 2019 - puj.journals.ekb.eg
Background: Anti-schistosome vaccination is a necessary approach to minimize the hepatic
vascular changes that lead to hepatic pathological consequences. Objective: To assess the …
vascular changes that lead to hepatic pathological consequences. Objective: To assess the …